glaxo

glaxo

Drugmaker reports 35% Y/Y jump in third-quarter adjusted profit, rev up 18% Y/Y

** GLAX's profit growth driven by strong demand for its respiratory drugs and antibiotic Augmentin, while demand for its vaccines also boosted earnings

Read More

Share:

Latest News